Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ALS
ALS
Biogen Halts ALS Asset Agreement with Karyopharm
BioSpace
Thu, 06/16/22 - 10:25 am
Biogen
Karyopharm Therapeutics
ALS
KPT-350
Amylyx gets first approval for ALS drug from Canada
Yahoo/Reuters
Mon, 06/13/22 - 10:42 am
Amylyx Pharmaceuticals
ALS
Canada
Albrioza
After phase 3 fail, Biogen posts 12-month data cut to make case for ALS prospect
Fierce Biotech
Fri, 06/3/22 - 09:16 am
Biogen
Ionis Pharmaceuticals
ALS
clinical trials
antisense
SOD1-ALS
Go or no go? The FDA’s Amylyx dilemma
EP Vantage
Tue, 05/31/22 - 10:29 am
FDA
Amylyx
AMX0035
ALS
COVID-19
vaccines
Novavax
Moderna Therapeutics
Pfizer
Acadia Pharma
Bluebird Bio
Researchers Discover Potential New Treatment for ALS
BioSpace
Thu, 05/26/22 - 10:45 pm
ALS
NU-9
FDA approves oral formulation of old ALS drug, giving patients new treatment option in sorely needed field
Endpoints
Fri, 05/13/22 - 10:41 am
Mitsubishi Tanabe Pharma
ALS
Radicava
FDA
Amylyx Augments Case for ALS Drug Ahead of PDUFA Date
BioSpace
Thu, 05/5/22 - 11:30 pm
Amylx
AMX0035
ALS
FDA
An FDA panel reviewing Amylyx's ALS drug was moved by patient testimony—but they voted it down anyway
Fierce Biotech
Thu, 03/31/22 - 10:48 am
Amylyx
ALS
FDA
patients
AMX0035
New blow for ALS pipeline as Biogen and Ionis candidate fails Phase 1 trial
Pharmaforum
Tue, 03/29/22 - 10:54 am
Biogen
Ionis Pharmaceuticals
ALS
clinical trials
BIIB078
Amylyx to answer for single-study ALS application at FDA advisory panel
Fierce Biotech
Mon, 03/28/22 - 07:46 pm
Amylyx
ALS
clinical trials
FDA
FDA Clears the Way for NeuroSense's PrimeC Candidate for ALS
BioSpace
Tue, 03/22/22 - 10:46 am
NeuroSense Therapeutics
PrimeC
ALS
FDA
Amylyx takes its ALS program to Nasdaq, raising the stakes for the biotech's only drug
Endpoints
Fri, 12/17/21 - 11:01 am
Amylyx
ALS
funding
NASDAQ
Eli Lilly joins Verge Genomics’ $98M round as AI-discovered ALS drug nears clinic
MedCity News
Fri, 12/17/21 - 10:48 am
Verge Genomics
Eli Lilly
ALS
artificial intelligence
funding
House almost unanimously passes bipartisan bill to pump $500M into ALS drug R&D
Endpoints
Thu, 12/9/21 - 10:36 am
legislation
ALS
R*D
Research Roundup: A Potential Cause of Alzheimer’s Disease and More
BioSpace
Fri, 12/3/21 - 10:52 am
R&D
Alzheimer's disease
ALS
Lyme disease
Amylyx asks FDA to approve ALS drug, while also preparing late-stage study
BioPharma Dive
Tue, 11/2/21 - 10:58 am
Amylyx Pharmaceuticals
AMX-0035
FDA
ALS
ANA 2021 – Ionis rocked by tofersen flop
EP Vantage
Mon, 10/18/21 - 10:58 am
Biogen
Ionis Pharmaceuticals
clinical trials
ALS
tofersen
Biogen Announces Topline Results from the Tofersen Phase 3 Study and its Open-Label Extension in SOD1-ALS
Yahoo Finance
Sun, 10/17/21 - 11:04 pm
Biogen
tofersen
clinical trials
ALS
Denali Moving Forward with Sanofi-Partnered ALS Candidate
BioSpace
Thu, 10/7/21 - 12:17 pm
Denali Therapeutics
Sanofi
ALS
DNL343
clinical trials
Biogen leads the amyotrophic lateral sclerosis hopefuls
EP Vantage
Thu, 09/16/21 - 10:41 am
ALS
Amylx
Biogen
Ionis Pharmaceuticals
AB Science
Cytokinetics
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »